These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 356963)

  • 1. Covalent intercalative binding to DNA in relation to the mutagenicity of hydrocarbon epoxides and N-acetoxy-2-acetylaminofluorene.
    Drinkwater NR; Miller JA; Miller EC; Yang NC
    Cancer Res; 1978 Oct; 38(10):3247-55. PubMed ID: 356963
    [No Abstract]   [Full Text] [Related]  

  • 2. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 3. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis.
    Sims P; Grover PL
    Adv Cancer Res; 1974; 20():165-274. PubMed ID: 4617500
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenic effects of styrene and styrene oxide.
    Busk L
    Mutat Res; 1979 Jul; 67(3):291-8. PubMed ID: 384233
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts.
    Day BW; Naylor S; Gan LS; Sahali Y; Nguyen TT; Skipper PL; Wishnok JS; Tannenbaum SR
    Cancer Res; 1990 Aug; 50(15):4611-8. PubMed ID: 2369737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of methylvinyl ketone in Salmonella typhimurium TA100--indication for epoxidation as an activation mechanism.
    Neudecker T; Eder E; Deininger C; Hoffman C; Henschler D
    Mutat Res; 1989 Oct; 227(2):131-4. PubMed ID: 2677713
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutagenicity of the metabolites of the epoxide-diol pathway of safrole and its analogs. Study on Salmonella typhimurium].
    Dorange JL; Delaforge M; Janiaud P; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1041-8. PubMed ID: 146546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supercoiled DNA.
    Bauer WR; Crick FH; White JH
    Sci Am; 1980 Jul; 243(1):100-13. PubMed ID: 6256851
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and mutagenicity of styrene and styrene oxide.
    Vainio H; Norppa H; Belvedere G
    Prog Clin Biol Res; 1984; 141():215-25. PubMed ID: 6718374
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of aliphatic epoxides.
    Wade DR; Airy SC; Sinsheimer JE
    Mutat Res; 1978 Nov; 58(2-3):217-23. PubMed ID: 370573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicities of styrene oxide derivatives on Salmonella typhimurium (TA 100): relationship between mutagenic potencies and chemical reactivity.
    Sugiura K; Kimura T; Goto M
    Mutat Res; 1978 Nov; 58(2-3):159-65. PubMed ID: 370568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Differential mutagenicity of epoxides.
    Glatt HR; Oesch R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R75. PubMed ID: 1143492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.